Genetic Variation in miR-27a Is Associated with Fluoropyrimidine-Associated Toxicity in Patients with Dihydropyrimidine Dehydrogenase Variants after Genotype-Guided Dose Reduction by Samantha Medwid, Theodore J. Wigle, Cameron Ross, Richard B. Kim

Get full text

<i>DPYD</i> Exon 4 Deletion Associated with Fluoropyrimidine Toxicity and Importance of Copy Number Variation by Theodore J. Wigle, Samantha Medwid, Cameron Ross, Ute I. Schwarz, Richard B. Kim

Get full text

Organic Anion Transporting Polypeptide 2B1 (OATP2B1) Genetic Variants: In Vitro Functional Characterization and Association With Circulating Concentrations of Endogenous Substrates by Samantha Medwid, Samantha Medwid, Hayley R. Price, Daniel P. Taylor, Jaymie Mailloux, Jaymie Mailloux, Ute I. Schwarz, Ute I. Schwarz, Richard B. Kim, Richard B. Kim, Richard B. Kim, Rommel G. Tirona, Rommel G. Tirona

Get full text

Impact of pretreatment dihydropyrimidine dehydrogenase genotype‐guided fluoropyrimidine dosing on chemotherapy associated adverse events by Theodore J. Wigle, Brandi L. Povitz, Samantha Medwid, Wendy A. Teft, Robin M. Legan, John Lenehan, Stephanie Nevison, Veera Panuganty, Denise Keller, Jaymie Mailloux, Victoria Siebring, Sisira Sarma, Yun‐hee Choi, Stephen Welch, Eric Winquist, Ute I. Schwarz, Richard B. Kim

Get full text